View in EDS HTML Full Text PDF Full Text

Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?

Saved in:
Bibliographic Details
Title: Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?
Authors: Cui, Li‐li1,2 (AUTHOR), Golubczyk, Dominika3 (AUTHOR), Tolppanen, Anna‐Maija4 (AUTHOR), Boltze, Johannes5 (AUTHOR), Jolkkonen, Jukka2,6 (AUTHOR) jukka.jolkkonen@uef.fi, Cui, Li-Li7,8 (AUTHOR), Tolppanen, Anna-Maija9 (AUTHOR)
Source: Annals of Neurology. Jul2019, Vol. 86 Issue 1, p5-16. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03645134
DOI:10.1002/ana.25493